Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
3.
Am J Med Sci ; 318(3): 203-5, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10487414

ABSTRACT

We describe a patient with a malignant carcinoid tumor who presented with severe, intractable hypercalcemia that would not respond to conventional therapy with fluids and pamidronate. His plasma concentrations of parathyroid-hormone-related peptide (PTHrP) and interleukin-6 (IL-6) were elevated. The patient was treated with subcutaneous injections of octreotide with a good response, resulting in normocalcemia. Plasma PTHrP and IL-6 fell with the octreotide but remained elevated above the upper limit of normal. We conclude that although rare, hypercalcemia may be associated with carcinoid tumors and may be mediated through the secretion of cytokines and or PTHrP. Treatment with octreotide may be effective in treating hypercalcemia in such patients.


Subject(s)
Antineoplastic Agents, Hormonal/therapeutic use , Carcinoid Tumor/drug therapy , Carcinoid Tumor/metabolism , Hypercalcemia/etiology , Interleukin-6/blood , Neoplasm Proteins/metabolism , Octreotide/therapeutic use , Parathyroid Hormone/metabolism , Proteins/metabolism , Aged , Antineoplastic Agents, Hormonal/administration & dosage , Carcinoid Tumor/blood , Carcinoid Tumor/secondary , Humans , Hypercalcemia/blood , Injections, Subcutaneous , Male , Neoplasm Proteins/blood , Octreotide/administration & dosage , Parathyroid Hormone/blood , Parathyroid Hormone-Related Protein , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...